Clinical Benefit of Continuing Crizotinib Therapy after Initial Disease Progression in Chinese Patients with Advanced ALK -Rearranged NSCLC

Journal of Thoracic Oncology(2017)

引用 0|浏览1
暂无评分
关键词
Treatment beyond disease progression,ALK rearrangement,crizotinib,Progression-free survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要